Thursday, February 13, 2014
On February 3, 2014, hundreds of individuals claiming to have been injured by defective hip implants manufactured and sold by Biomet, Inc. agreed to a settlement that will compensate them for their injuries.
According the plaintiffs’ claims, these defective medical devices use a metal-on-metal design that has been shown to generate high levels of metal ions that then infiltrate and infect surrounding tissue (known as metallosis), and have a higher than normal overall failure rate.
The settlement provides individuals who underwent revision surgeries after suffering metal-on-metal related failures of Biomet Magnum hip implant devices to receive a base award of $200,000, provided that the failure was not the result of infection, trauma, or other injury unrelated to the metal-on-metal design. Award amounts will be discounted according to various factors.
Additionally, Biomet has agreed to a provision that would allow the statute of limitations to commence on the date the individual undergoes revision surgery, giving plaintiffs a potentially larger period of time to file suit.
To be eligible for the settlement, the case must be filed on or before April 15, 2014. Click here to learn more about the details of the settlement.